J
Janet M. Sasso
Researcher at American Chemical Society
Publications - 7
Citations - 810
Janet M. Sasso is an academic researcher from American Chemical Society. The author has contributed to research in topics: Medicine & Nanocarriers. The author has an hindex of 1, co-authored 1 publications receiving 425 citations.
Papers
More filters
Journal ArticleDOI
Assay Techniques and Test Development for COVID-19 Diagnosis
Linda J. Carter,Linda V. Garner,Jeffrey Smoot,Yingzhu Li,Qiongqiong Zhou,Catherine J. Saveson,Janet M. Sasso,Anne C. Gregg,Divya J. Soares,Tiffany R. Beskid,Susan R. Jervey,Cynthia Liu +11 more
TL;DR: An ongoing theme of the COVID-19 pandemic is the need for widespread availability of accurate and efficient diagnostic testing for detection of SARS-CoV-2 and antiviral antibodies in infected indiv...
Journal ArticleDOI
Exosomes—Nature’s Lipid Nanoparticles, a Rising Star in Drug Delivery and Diagnostics
TL;DR: Exosomes are a subgroup of nanosized extracellular vesicles enclosed by a lipid bilayer membrane and secreted by most eukaryotic cells as mentioned in this paper , which represent a route of intercellular communication and participate in a wide variety of physiological and pathological processes.
Journal ArticleDOI
The Progress and Promise of RNA Medicine—An Arsenal of Targeted Treatments
Janet M. Sasso,Barbara J B Ambrose,Rumiana Tenchov,Ruchira S. Datta,Matthew T. Basel,Robert K. Delong,Qiongqiong Zhou +6 more
TL;DR: A landscape view of the current state and outline trends in RNA research in medicine across time, geography, therapeutic pipelines, chemical modifications, and delivery mechanisms is provided.
Journal ArticleDOI
Molecular Glues: The Adhesive Connecting Targeted Protein Degradation to the Clinic
TL;DR: This paper uses data from the CAS Content Collection and the publication landscape of recent research on targeted protein degraders to provide insights into these molecules, with a special focus on molecular glues.
Journal ArticleDOI
PEGylated Lipid Nanoparticle Formulations: Immunological Safety and Efficiency Perspective
TL;DR: In this article , the authors present an overview based on analysis of data from the CAS Content Collection regarding the PEGylated LNP immunogenicity and overall safety concerns, and a comprehensive summary has been compiled outlining how various structural parameters of the polyethylene glycol (PEG)-lipids affect the immune responses and activities of the LNPs, with regards to their efficiency in drug delivery.